Because ACP, which is considered a benign tumor, carries a low rate of somatic mutations, mounting evidence suggests that the TGF-β, ERBB2 and SHH signaling pathways are involved in tumor formation in an autocrine or paracrine manner. The gene discussed is ERBB2; the disease is neoplasm.